标题
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia
作者
关键词
mGlu receptor, Schizophrenia, Allosteric modulator, Signal bias, Heterodimer, PAM, NAM, Glutamate
出版物
Molecular Brain
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-04-26
DOI
10.1186/s13041-017-0293-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Metabotropic glutamate receptor 2 inhibits thalamically-driven glutamate and dopamine release in the dorsal striatum
- (2017) Kari A. Johnson et al. NEUROPHARMACOLOGY
- The impact of metabotropic glutamate receptors into active neurodegenerative processes: A “dark side” in the development of new symptomatic treatments for neurologic and psychiatric disorders
- (2017) Valeria Bruno et al. NEUROPHARMACOLOGY
- Development and Antiparkinsonian Activity of VU0418506, a Selective Positive Allosteric Modulator of Metabotropic Glutamate Receptor 4 Homomers without Activity at mGlu2/4 Heteromers
- (2016) Colleen M. Niswender et al. ACS Chemical Neuroscience
- Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 3. Engineering plasma stability by discovery and optimization of isoindolinone analogs
- (2016) Pedro M. Garcia-Barrantes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Lead optimization of the VU0486321 series of mGlu 1 PAMs. Part 2: SAR of alternative 3-methyl heterocycles and progress towards an in vivo tool
- (2016) Pedro M. Garcia-Barrantes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Re-exploration of the mGlu1 PAM Ro 07-11401 scaffold: Discovery of analogs with improved CNS penetration despite steep SAR
- (2016) Pedro M. Garcia-Barrantes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Involvement of GABABReceptor Signaling in Antipsychotic-like Action of the Novel Orthosteric Agonist of the mGlu4Receptor, LSP4-2022
- (2016) Monika Woźniak et al. Current Neuropharmacology
- Positive Allosteric Modulators of GluN2A-Containing NMDARs with Distinct Modes of Action and Impacts on Circuit Function
- (2016) David H. Hackos et al. NEURON
- An mGlu5-Positive Allosteric Modulator Rescues the Neuroplasticity Deficits in a Genetic Model of NMDA Receptor Hypofunction in Schizophrenia
- (2016) Darrick T Balu et al. NEUROPSYCHOPHARMACOLOGY
- Stimulation of the metabotropic glutamate (mGlu) 2 receptor attenuates the MK-801-induced increase in the immobility time in the forced swimming test in rats
- (2016) Kazuaki Kawaura et al. Pharmacological Reports
- Metabotropic glutamate receptors as targets for new antipsychotic drugs: Historical perspective and critical comparative assessment
- (2016) Joanna M. Wierońska et al. PHARMACOLOGY & THERAPEUTICS
- AZD8529, a positive allosteric modulator at the mGluR2 receptor, does not improve symptoms in schizophrenia: A proof of principle study
- (2016) Robert E. Litman et al. SCHIZOPHRENIA RESEARCH
- Allosteric signaling through an mGlu2 and 5-HT2Aheteromeric receptor complex and its potential contribution to schizophrenia
- (2016) José L. Moreno et al. Science Signaling
- Phasic and Tonic mGlu7 Receptor Activity Modulates the Thalamocortical Network
- (2016) Valériane Tassin et al. Frontiers in Neural Circuits
- The mGluR2 positive allosteric modulator, SAR218645, improves memory and attention deficits in translational models of cognitive symptoms associated with schizophrenia
- (2016) Guy Griebel et al. Scientific Reports
- Allosteric signaling through an mGlu2 and 5-HT2Aheteromeric receptor complex and its potential contribution to schizophrenia
- (2016) José L. Moreno et al. Science Signaling
- Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment
- (2016) Jeremy S. Lum et al. Scientific Reports
- Lead optimization of the VU0486321 series of mGlu1 PAMs. Part 1: SAR of modifications to the central aryl core
- (2015) Pedro M. Garcia-Barrantes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Antipsychotic medication in schizophrenia: a review
- (2015) John Lally et al. BRITISH MEDICAL BULLETIN
- Group I and group II metabotropic glutamate receptor allosteric modulators as novel potential antipsychotics
- (2015) Adam G Walker et al. CURRENT OPINION IN PHARMACOLOGY
- LY395756, an mGluR2 agonist and mGluR3 antagonist, enhances NMDA receptor expression and function in the normal adult rat prefrontal cortex, but fails to improve working memory and reverse MK801-induced working memory impairment
- (2015) Meng-Lin Li et al. EXPERIMENTAL NEUROLOGY
- Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile)
- (2015) John A. Christopher et al. JOURNAL OF MEDICINAL CHEMISTRY
- Activation of Metabotropic Glutamate Receptor 7 Is Required for Induction of Long-Term Potentiation at SC-CA1 Synapses in the Hippocampus
- (2015) R. Klar et al. JOURNAL OF NEUROSCIENCE
- Antipsychotic profiles of TASP0443294, a novel and orally active positive allosteric modulator of metabotropic glutamate 2 receptor
- (2015) Hirohiko Hikichi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Pharmacokinetic and pharmacodynamic characterisation of JNJ-40411813, a positive allosteric modulator of mGluR2, in two randomised, double-blind phase-I studies
- (2015) Hiba Salih et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials
- (2015) Y Iwata et al. MOLECULAR PSYCHIATRY
- Biased mGlu 5 -Positive Allosteric Modulators Provide In Vivo Efficacy without Potentiating mGlu 5 Modulation of NMDAR Currents
- (2015) Jerri M. Rook et al. NEURON
- Metabotropic glutamate receptor 3 activation is required for long-term depression in medial prefrontal cortex and fear extinction
- (2015) Adam G. Walker et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Neuroinflammation and white matter pathology in schizophrenia: systematic review
- (2015) Souhel Najjar et al. SCHIZOPHRENIA RESEARCH
- Chemical Modulation of Mutant mGlu1 Receptors Derived from Deleterious GRM1 Mutations Found in Schizophrenics
- (2014) Hyekyung P. Cho et al. ACS Chemical Biology
- A double-blind, placebo-controlled comparator study of LY2140023 monohydrate in patients with schizophrenia
- (2014) AnnCatherine M Downing et al. BMC Psychiatry
- Design and Synthesis of Systemically Active Metabotropic Glutamate Subtype-2 and -3 (mGlu2/3) Receptor Positive Allosteric Modulators (PAMs): Pharmacological Characterization and Assessment in a Rat Model of Cocaine Dependence
- (2014) Raveendra-Panickar Dhanya et al. JOURNAL OF MEDICINAL CHEMISTRY
- Selective Actions of Novel Allosteric Modulators Reveal Functional Heteromers of Metabotropic Glutamate Receptors in the CNS
- (2014) S. Yin et al. JOURNAL OF NEUROSCIENCE
- Localized GABAergic inhibition of dendritic Ca2+ signalling
- (2014) Michael J. Higley NATURE REVIEWS NEUROSCIENCE
- Group III Metabotropic Glutamate Receptors: Pharmacology, Physiology and Therapeutic Potential
- (2014) Marion S. Mercier et al. NEUROCHEMICAL RESEARCH
- Structure of a Class C GPCR Metabotropic Glutamate Receptor 1 Bound to an Allosteric Modulator
- (2014) H. Wu et al. SCIENCE
- Serotonin and dopamine receptors in motivational and cognitive disturbances of schizophrenia
- (2014) Tomiki Sumiyoshi et al. Frontiers in Neuroscience
- The reversal of cognitive, but not negative or positive symptoms of schizophrenia, by the mGlu2/3 receptor agonist, LY379268, is 5-HT1A dependent
- (2013) Joanna M. Wierońska et al. BEHAVIOURAL BRAIN RESEARCH
- A long-term, phase 2, multicenter, randomized, open-label, comparative safety study of pomaglumetad methionil (LY2140023 monohydrate) versus atypical antipsychotic standard of care in patients with schizophrenia
- (2013) David H Adams et al. BMC Psychiatry
- The antipsychotic-like effects of positive allosteric modulators of metabotropic glutamate mGlu4receptors in rodents
- (2013) Anna Sławińska et al. BRITISH JOURNAL OF PHARMACOLOGY
- A Prolyl-Isomerase Mediates Dopamine-Dependent Plasticity and Cocaine Motor Sensitization
- (2013) Joo Min Park et al. CELL
- Thalamocortical connectivity during resting state in schizophrenia
- (2013) Carsten M. Klingner et al. EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Differential regulation of CaMKIIα interactions with mGluR5 and NMDA receptors by Ca2+in neurons
- (2013) Dao-Zhong Jin et al. JOURNAL OF NEUROCHEMISTRY
- Stimulation of Metabotropic Glutamate (mGlu) 2 Receptor and Blockade of mGlu1 Receptor Improve Social Memory Impairment Elicited by MK-801 in Rats
- (2013) Hirohiko Hikichi et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- SNARE proteins are essential in the potentiation of NMDA receptors by group II metabotropic glutamate receptors
- (2013) Jia Cheng et al. JOURNAL OF PHYSIOLOGY-LONDON
- Modulation of behavior by scaffolding proteins of the post-synaptic density
- (2013) Can Gao et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Mechanism based neurotoxicity of mGlu5 positive allosteric modulators – Development challenges for a promising novel antipsychotic target
- (2013) Sophie Parmentier-Batteur et al. NEUROPHARMACOLOGY
- Multiple risk pathways for schizophrenia converge in serine racemase knockout mice, a mouse model of NMDA receptor hypofunction
- (2013) D. T. Balu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pomaglumetad methionil: No significant difference as an adjunctive treatment for patients with prominent negative symptoms of schizophrenia compared to placebo
- (2013) Virginia L. Stauffer et al. SCHIZOPHRENIA RESEARCH
- Group II metabotropic glutamate receptors modify N-methyl-D-aspartate receptors via Src kinase
- (2013) Catherine Trepanier et al. Scientific Reports
- Glutamate Levels in the Associative Striatum Before and After 4 Weeks of Antipsychotic Treatment in First-Episode Psychosis
- (2013) Camilo de la Fuente-Sandoval et al. JAMA Psychiatry
- Update on Typical and Atypical Antipsychotic Drugs
- (2012) Herbert Y. Meltzer Annual Review of Medicine
- Unique Signaling Profiles of Positive Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Determine Differences in In Vivo Activity
- (2012) Jerri M. Rook et al. BIOLOGICAL PSYCHIATRY
- Therapeutic effects of metabotropic glutamate receptor 5 positive allosteric modulator CDPPB on phencyclidine-induced cognitive deficits in mice
- (2012) Mao Horio et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study
- (2012) Camilo de la Fuente-Sandoval et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Dynamic remodeling of scaffold interactions in dendritic spines controls synaptic excitability
- (2012) Enora Moutin et al. JOURNAL OF CELL BIOLOGY
- PGC-1 Negatively Regulates Extrasynaptic NMDAR Activity and Excitotoxicity
- (2012) C. Puddifoot et al. JOURNAL OF NEUROSCIENCE
- Opposing Roles of Synaptic and Extrasynaptic NMDA Receptor Signaling in Cocultured Striatal and Cortical Neurons
- (2012) A. M. Kaufman et al. JOURNAL OF NEUROSCIENCE
- Preso1 dynamically regulates group I metabotropic glutamate receptors
- (2012) Jia-Hua Hu et al. NATURE NEUROSCIENCE
- HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity
- (2012) Mitsumasa Kurita et al. NATURE NEUROSCIENCE
- Pharmacological modulation of NMDA receptor activity and the advent of negative and positive allosteric modulators
- (2012) Daniel T. Monaghan et al. NEUROCHEMISTRY INTERNATIONAL
- mGlu3 receptor and astrocytes: Partners in neuroprotection
- (2012) Daniela Durand et al. NEUROPHARMACOLOGY
- Modulation of pyramidal cell output in the medial prefrontal cortex by mGluR5 interacting with CB1
- (2012) Takaki Kiritoshi et al. NEUROPHARMACOLOGY
- Clinical development of pomaglumetad methionil: A non-dopaminergic treatment for schizophrenia
- (2012) Bruce J. Kinon et al. NEUROPHARMACOLOGY
- Synergy between l-DOPA and a novel positive allosteric modulator of metabotropic glutamate receptor 4: Implications for Parkinson's disease treatment and dyskinesia
- (2012) Khaled-Ezaheir Bennouar et al. NEUROPHARMACOLOGY
- Neuronal d-serine regulates dendritic architecture in the somatosensory cortex
- (2012) Darrick T. Balu et al. NEUROSCIENCE LETTERS
- Deleterious GRM1 Mutations in Schizophrenia
- (2012) Mohammed Akli Ayoub et al. PLoS One
- Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs
- (2011) Miguel Fribourg et al. CELL
- A Multicenter, Inpatient, Phase 2, Double-Blind, Placebo-Controlled Dose-Ranging Study of LY2140023 Monohydrate in Patients With DSM-IV Schizophrenia
- (2011) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- The Metabotropic Glutamate Receptor 7 Allosteric Modulator AMN082: A Monoaminergic Agent in Disguise?
- (2011) S. J. Sukoff Rizzo et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- mGluR8 Modulates Excitatory Transmission in the Bed Nucleus of the Stria Terminalis in a Stress-Dependent Manner
- (2011) Heather B Gosnell et al. NEUROPSYCHOPHARMACOLOGY
- Pharmacological Activation of Group-II Metabotropic Glutamate Receptors Corrects a Schizophrenia-Like Phenotype Induced by Prenatal Stress in Mice
- (2011) Francesco Matrisciano et al. NEUROPSYCHOPHARMACOLOGY
- From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment
- (2011) Bita Moghaddam et al. NEUROPSYCHOPHARMACOLOGY
- Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel mGlu5 Positive Allosteric Modulator
- (2011) Francois Gastambide et al. NEUROPSYCHOPHARMACOLOGY
- Clustered Coding Variants in the Glutamate Receptor Complexes of Individuals with Schizophrenia and Bipolar Disorder
- (2011) René A. W. Frank et al. PLoS One
- Neuroinflammation in schizophrenia especially focused on the role of microglia
- (2011) Akira Monji et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effects of a novel mGlu2/3 receptor agonist prodrug, LY2140023 monohydrate, on central monoamine turnover as determined in human and rat cerebrospinal fluid
- (2011) Stephen Lowe et al. PSYCHOPHARMACOLOGY
- Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia
- (2011) Joanna M. Wierońska et al. PSYCHOPHARMACOLOGY
- Alterations in Metabotropic Glutamate Receptor 1α and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia
- (2010) David W. Volk et al. AMERICAN JOURNAL OF PSYCHIATRY
- Metabotropic Glutamate Receptors: Physiology, Pharmacology, and Disease
- (2010) Colleen M. Niswender et al. Annual Review of Pharmacology and Toxicology
- An orally bioavailable positive allosteric modulator of the mGlu4 receptor with efficacy in an animal model of motor dysfunction
- (2010) Stephen P. East et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Memory for Fear Extinction Requires mGluR5-Mediated Activation of Infralimbic Neurons
- (2010) Darah E. Fontanez-Nuin et al. CEREBRAL CORTEX
- Effects of metabotropic glutamate receptor 2/3 agonism and antagonism on schizophrenia-like cognitive deficits induced by phencyclidine in rats
- (2010) Nurith Amitai et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Functional interaction of metabotropic glutamate receptor 5 and NMDA-receptor by a metabotropic glutamate receptor 5 positive allosteric modulator
- (2010) Holger Rosenbrock et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade
- (2010) Mark R. Stefani et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- A new approach to analyze cell surface protein complexes reveals specific heterodimeric metabotropic glutamate receptors
- (2010) Etienne Doumazane et al. FASEB JOURNAL
- Effects of a Positive Allosteric Modulator of Group II Metabotropic Glutamate Receptors, LY487379, on Cognitive Flexibility and Impulsive-Like Responding in Rats
- (2010) A. Nikiforuk et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Discovery of Novel Allosteric Modulators of Metabotropic Glutamate Receptor Subtype 5 Reveals Chemical and Functional Diversity and In Vivo Activity in Rat Behavioral Models of Anxiolytic and Antipsychotic Activity
- (2010) A. L. Rodriguez et al. MOLECULAR PHARMACOLOGY
- Metabotropic glutamate receptors: From the workbench to the bedside
- (2010) F. Nicoletti et al. NEUROPHARMACOLOGY
- MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?
- (2010) Joshua D. Vardigan et al. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
- Association analysis of GRM2 and HTR2A with methamphetamine-induced psychosis and schizophrenia in the Japanese population
- (2010) Tomoko Tsunoka et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- The mGluR2/3 agonist LY379268 reverses post-weaning social isolation-induced recognition memory deficits in the rat
- (2010) Caitlin A. Jones et al. PSYCHOPHARMACOLOGY
- Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia
- (2009) Oliver D. Howes et al. ARCHIVES OF GENERAL PSYCHIATRY
- 3-Benzyl-1,3-oxazolidin-2-ones as mGluR2 positive allosteric modulators: Hit-to lead and lead optimization
- (2009) Allen J. Duplantier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Comparison of the mGlu5 receptor positive allosteric modulator ADX47273 and the mGlu2/3 receptor agonist LY354740 in tests for antipsychotic-like activity
- (2009) Chantal Schlumberger et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Unique Antipsychotic Activities of the Selective Metabotropic Glutamate Receptor 1 Allosteric Antagonist 2-Cyclopropyl-5-[1-(2-fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-2,3-dihydro-1H-isoindol-1-one
- (2009) A. Satow et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Schizophrenia
- (2009) Jim van Os et al. LANCET
- mGluR5 Positive Allosteric Modulators Facilitate both Hippocampal LTP and LTD and Enhance Spatial Learning
- (2009) Jennifer E Ayala et al. NEUROPSYCHOPHARMACOLOGY
- Further evidence for a functional role of the glutamate receptor gene GRM3 in schizophrenia
- (2008) Rainald Mössner et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Pharmacological Effects of the Metabotropic Glutamate Receptor 1 Antagonist Compared with Those of the Metabotropic Glutamate Receptor 5 Antagonist and Metabotropic Glutamate Receptor 2/3 Agonist in Rodents: Detailed Investigations with a Selective Allosteric Metabotropic Glutamate Receptor 1 Antagonist, FTIDC [4-[1-(2-Fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide]
- (2008) A. Satow et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Evidence for the Role of Metabotropic Glutamate (mGlu)2 Not mGlu3 Receptors in the Preclinical Antipsychotic Pharmacology of the mGlu2/3 Receptor Agonist (-)-(1R,4S,5S,6S)-4-Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic Acid (LY404039)
- (2008) M. J. Fell et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Review: The group II metabotropic glutamate receptor 3 (mGluR3, mGlu3, GRM3): expression, function and involvement in schizophrenia
- (2008) PJ Harrison et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Identification of a serotonin/glutamate receptor complex implicated in psychosis
- (2008) Javier González-Maeso et al. NATURE
- Deficits in acquisition and extinction of conditioned responses in mGluR7 knockout mice
- (2008) Hannelore Goddyn et al. NEUROBIOLOGY OF LEARNING AND MEMORY
- Peripheral administration of group III mGlu receptor agonist ACPT-I exerts potential antipsychotic effects in rodents
- (2008) A. Pałucha-Poniewiera et al. NEUROPHARMACOLOGY
- Activation of metabotropic glutamate 5 (mGlu5) receptors induces spontaneous excitatory synaptic currents in layer V pyramidal cells of the rat prefrontal cortex
- (2008) Gerard J. Marek et al. NEUROSCIENCE LETTERS
- A polymorphism of the metabotropic glutamate receptor mGluR7 (GRM7) gene is associated with schizophrenia
- (2008) Tsuyuka Ohtsuki et al. SCHIZOPHRENIA RESEARCH
- Activation of metabotropic glutamate receptors as a novel approach for the treatment of schizophrenia
- (2008) P. Jeffrey Conn et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Group III mGluR regulation of synaptic transmission at the SC-CA1 synapse is developmentally regulated
- (2007) Jennifer E. Ayala et al. NEUROPHARMACOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started